Page last updated: 2024-08-17

levodopa and Supranuclear Palsy, Progressive

levodopa has been researched along with Supranuclear Palsy, Progressive in 75 studies

Research

Studies (75)

TimeframeStudies, this research(%)All Research%
pre-19902 (2.67)18.7374
1990's23 (30.67)18.2507
2000's20 (26.67)29.6817
2010's20 (26.67)24.3611
2020's10 (13.33)2.80

Authors

AuthorsStudies
Borsek, M; Jeleňová, B; Necpál, J1
Ahlskog, JE; Ali, F; Botha, H; Carlos, AF; Clark, HM; Coon, EA; Dickson, DW; Josephs, KA; Koga, S; Lowe, V; Pham, NTT; Sekiya, H; Trejo-Lopez, JA; Whitwell, JL1
Adachi, T; Hanajima, R; Hasegawa, M; Sakata, R; Sakuwa, M; Suzuki, Y; Takigawa, H1
Arai, H; Kunitoki, K; Mutoh, T; Taki, Y1
Galazky, I; Heinze, HJ; Hinrichs, H; Kupsch, A; Neumann, J; Sweeney-Reed, CM; Voges, J; Zaehle, T1
Park, JE1
Ishida, C; Kato-Motozaki, Y; Komai, K; Tagami, A; Takahashi, K1
Cairns, NJ; Criswell, S; Davis, AA; Hartlein, J; Kotzbauer, PT; Maiti, B; Martin, WRW; Miles, M; Norris, SA; Perlmutter, JS; Perrin, RJ; Racette, BA; Ushe, M; Zhong, Q1
Blinova, NM; Derevyanko, HP; Safin, SM1
Ju, H; Kwon, KY; Lee, EJ; Lee, M1
Bril, EV; Fedorova, NV; Kulua, TK; Mikhaylova, AD1
Avenali, M; De Icco, R; Fresia, M; Pacchetti, C; Perrotta, A; Sandrini, G; Serrao, M; Tassorelli, C1
Ali, F; Josephs, KA1
Gulmez Sevim, D; Gultekin, M; Karaca, C; Mirza, GE; Mirza, M; Unlu, M1
Buhmann, C; Hauptmann, B; Modreanu, R; Özdemir, G1
Buhmann, C; Jost, WH; Kassubek, J; Lingor, P; Schrag, A; Schwarz, J; Tönges, L1
Greene, P1
Aoki, M; Hasegawa, T; Kaneko, K; Kikuchi, A; Takeda, A; Tano, O1
Bergquist, F; Eklund, M; Holmberg, B; Thorlin, T; Zackrisson, T1
Hagiwara, M; Kasahata, N; Kato, H; Nakamura, A; Uchihara, T1
Bhidayasiri, R; Boonrod, N; Jitkritsadakul, O; Rerknimitr, R1
Ben M' Barek, L; Di Ruscio, P; Onofrj, M; Thomas, A; Varanese, S1
Pradhan, S; Tandon, R1
Algom, AA; Dickson, DW; Fujioka, S; Murray, ME; Rademakers, R; Ross, OA; Sanchez-Contreras, MY; Tacik, P; Tsuboi, Y; Uitti, RJ; Van Gerpen, JA; Wszolek, ZK1
Aguiar, PM; Barsottini, OG; Borges, V; Felício, AC; Ferraz, HB; Godeiro-Junior, C; Silva, SM1
Compta, Y; Ezquerra, M; Martí, MJ; Rey, MJ1
Kapsoritakis, AN; Kardasi, M; Manolakis, AC; Potamianos, SP; Psychos, AK; Tsiopoulos, FD1
Dziewas, R; Hamacher, C; Lohmann, H; Oelenberg, S; Ringelstein, EB; Teismann, I; Warnecke, T1
Tison, F1
Ben-Djebara, M; Gargouri, A; Gouider, R; Kacem, I1
Brown, P; Day, BL; Lees, AJ; Ling, H; Massey, LA1
Gawel, D; Gawel, M; Jamrozik, Z; Kaminska, A; Rowińska-Marcińska, K; Slawek, J; Szmidt-Salkowska, E1
Choe, GY; Choi, YL; Jeon, BS; Kim, JM; Lee, KH1
Birdi, S; Donat, JR; Fenton, M; George, D; Macaulay, R; Rajput, AH; Robinson, C; Rozdilsky, B1
Aniello, MS; De Mari, M; Defazio, G; Lamberti, P; Zenzola, A1
Chan, LL; Tan, EK; Wong, MC1
Rajput, A; Rajput, AH; Robinson, CA1
Drozdowski, W; Halicka, D; Kułakowska, A; Pogorzelski, R; Pyd, E1
Benecke, R; Classen, J; Grossmann, A; Kunesch, E; Wolters, A1
al-Din, AS; Hadeed, A; Lees, AJ; Williams, DR; Wreikat, AL1
Lang, AE1
Pavanni, R; Tan, EK; Tong, J; Wong, MC; Zhao, Y1
Bergmann, KJ; Salak, VL1
Halliday, GM; Hardman, CD; Karaconji, T; Murphy, KE1
Brown, P; Doyle, LM; Lees, AJ; Williams, DR1
Duvoisin, RC; Mark, MH; Miller, DC; Sage, JI; Walters, AS1
Boonen, S; Celen, H; Dom, R; Pelemans, W1
Fukuuchi, Y; Kobari, M; Nogawa, S; Obara, K; Shinohara, T1
Playford, ED1
Imai, H1
Fénelon, G; Feve, A; Guillard, A; Mahieux, F; Romatet, S1
Golbe, LI; Nieforth, KA1
Imai, H; Kondo, T; Nakamura, T; Narabayashi, H1
Chaudhuri, KR; D'Olhaberriague, L; Jellinger, K; Litvan, I; Mangone, CA; McKee, A; Parsa, A; Pearce, RK; Verny, M1
Campbell, G; Chaudhuri, KR; D'Olhaberriague, L; Jellinger, K; Litvan, I; Mangone, CA; McKee, A; Pearce, RK; Verny, M1
Almeida, OP; Tamai, S1
Mizuno, Y; Yanagisawa, N1
De Mari, M; Federico, F; Giannini, P; Iliceto, G; Lamberti, P; Lucivero, V; Mezzapesa, DM; Simone, IL; Tarantino, A1
Nishimiya, J; Yuasa, T1
Bentivoglio, AR; Daniele, A; Moro, E1
Calmes, J; Hendersen, N; Jankovic, J; Olson, S; Ondo, W; Overby, A; Warrior, D1
Ağan, K; Aktan, S; Gunal, DI1
Eriksson, B; Holmberg, B; Ingvarsson, P; Johnels, B; Rosengren, L1
Ferrarini, M; Filippini, G; Girotti, F; Monza, D; Soliveri, P; Testa, D1
Dubas, F; Henin, D; Vidailhet, M1
Fukuuchi, Y; Kobari, M; Nogawa, S; Shinohara, T; Takahashi, K1
Calne, DB; Cooper, S; Cordes, M; Morrison, S; Schofield, P; Snow, BJ; Sossi, V; Takahashi, H1
Bannister, R; Brooks, DJ; Frackowiak, RS; Ibanez, V; Lees, AJ; Marsden, CD; Mathias, CJ; Playford, ED; Quinn, N; Sawle, GV1
Abbott, RJ; D'Costa, DF; Millac, PA; Pye, IF1
Ahlskog, JE; Fealey, RD; Low, PA; Sandroni, P1
Agid, Y; Holemans, S; Javoy, F; Laterre, EC; Maloteaux, JM1
Chung, MY; Lan, C1
Sandyk, R1
Homma, Y; Ikuta, F; Takahashi, H; Takeda, S1

Reviews

10 review(s) available for levodopa and Supranuclear Palsy, Progressive

ArticleYear
"Parkinson's disease" on the way to progressive supranuclear palsy: a review on PSP-parkinsonism.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2021, Volume: 42, Issue:12

    Topics: Humans; Levodopa; Parkinson Disease; Parkinsonian Disorders; Supranuclear Palsy, Progressive; Systematic Reviews as Topic

2021
[Progressive supranuclear palsy].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2021, Volume: 121, Issue:5

    Topics: Humans; Levodopa; Middle Aged; Neurodegenerative Diseases; Neuroimaging; Parkinson Disease; Supranuclear Palsy, Progressive

2021
Dyskinesia in multiple system atrophy and progressive supranuclear palsy.
    Journal of neural transmission (Vienna, Austria : 1996), 2019, Volume: 126, Issue:7

    Topics: Diagnosis, Differential; Dyskinesia, Drug-Induced; Dyskinesias; Humans; Levodopa; Multiple System Atrophy; Parkinson Disease; Supranuclear Palsy, Progressive

2019
Progressive Supranuclear Palsy, Corticobasal Degeneration, and Multiple System Atrophy.
    Continuum (Minneapolis, Minn.), 2019, Volume: 25, Issue:4

    Topics: Aged; Basal Ganglia Diseases; Diagnosis, Differential; Dopamine Agents; Female; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Supranuclear Palsy, Progressive

2019
["Red flags": when to be alerted and how to explore?].
    Revue neurologique, 2010, Volume: 166, Issue:10

    Topics: Antiparkinson Agents; Basal Ganglia Diseases; Biomarkers; Diagnosis, Differential; Humans; Levodopa; Lewy Body Disease; Magnetic Resonance Imaging; Multiple System Atrophy; Parkinson Disease; Supranuclear Palsy, Progressive

2010
Clinical and single-photon emission computed tomography study of pure akinesia with freezing of gait.
    Neurosciences (Riyadh, Saudi Arabia), 2012, Volume: 17, Issue:1

    Topics: Diagnosis, Differential; Dopamine Agents; Gait Apraxia; Humans; Levodopa; Male; Middle Aged; Morocco; Speech Disorders; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon

2012
Positron emission tomography: applications to the investigation of movement disorders.
    European journal of clinical investigation, 1994, Volume: 24, Issue:7

    Topics: Cerebrovascular Circulation; Humans; Levodopa; Movement; Movement Disorders; Parkinson Disease; Supranuclear Palsy, Progressive; Tomography, Emission-Computed

1994
[Festination and freezing].
    Rinsho shinkeigaku = Clinical neurology, 1993, Volume: 33, Issue:12

    Topics: Gait; Humans; Levodopa; Movement Disorders; Supranuclear Palsy, Progressive

1993
[Progressive supranuclear palsy (PSP)].
    Ryoikibetsu shokogun shirizu, 1999, Issue:27 Pt 2

    Topics: Diagnosis, Differential; Dopamine Agents; Humans; Levodopa; Magnetic Resonance Imaging; Prognosis; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

1999
[Parkinson disease: diagnostic and therapeutic criteria].
    Presse medicale (Paris, France : 1983), 2001, Mar-03, Volume: 30, Issue:8

    Topics: Activities of Daily Living; Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Female; Globus Pallidus; Humans; Indoles; Levodopa; Lewy Body Disease; Lisuride; Male; Mental Status Schedule; Neurosurgery; Parkinson Disease; Parkinsonian Disorders; Piribedil; Psychiatric Status Rating Scales; Serotonin Receptor Agonists; Stereotaxic Techniques; Supranuclear Palsy, Progressive; Surveys and Questionnaires; Thalamus

2001

Trials

3 trial(s) available for levodopa and Supranuclear Palsy, Progressive

ArticleYear
Compassionate trial of levodopa carbidopa intestinal gel infusion in two patients with progressive supranuclear palsy.
    Clinical neurology and neurosurgery, 2014, Volume: 116

    Topics: Aged; Antiparkinson Agents; Carbidopa; Compassionate Use Trials; Female; Gels; Humans; Levodopa; Male; Parkinson Disease; Supranuclear Palsy, Progressive; Treatment Outcome

2014
Zolpidem in progressive supranuclear palsy.
    The New England journal of medicine, 1999, Aug-12, Volume: 341, Issue:7

    Topics: Cross-Over Studies; Humans; Hypnotics and Sedatives; Levodopa; Male; Middle Aged; Pilot Projects; Pyridines; Supranuclear Palsy, Progressive; Zolpidem

1999
CSF-neurofilament and levodopa tests combined with discriminant analysis may contribute to the differential diagnosis of Parkinsonian syndromes.
    Parkinsonism & related disorders, 2001, Volume: 8, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Algorithms; Antiparkinson Agents; Diagnosis, Differential; Discriminant Analysis; Female; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Nerve Degeneration; Neurofilament Proteins; Parkinsonian Disorders; Spinal Puncture; Supranuclear Palsy, Progressive

2001

Other Studies

62 other study(ies) available for levodopa and Supranuclear Palsy, Progressive

ArticleYear
Tau-PET and multimodal imaging in clinically atypical multiple system atrophy masquerading as progressive supranuclear palsy.
    Parkinsonism & related disorders, 2022, Volume: 101

    Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Levodopa; Magnetic Resonance Imaging; Multimodal Imaging; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Supranuclear Palsy, Progressive

2022
An autopsy case of progressive supranuclear palsy. Pallido-nigro-luysian type with argyrophilic grains clinically presenting with personality and behavioral changes.
    Neuropathology : official journal of the Japanese Society of Neuropathology, 2022, Volume: 42, Issue:5

    Topics: Aged; Aged, 80 and over; Atrophy; Autopsy; Humans; Levodopa; Male; Neurodegenerative Diseases; Personality; Supranuclear Palsy, Progressive; tau Proteins

2022
Adverse motor effects of progressive supranuclear palsy with frontal lobe signs: A case report.
    Geriatrics & gerontology international, 2019, Volume: 19, Issue:11

    Topics: Donepezil; Female; Frontal Lobe; Humans; Levodopa; Middle Aged; Single Photon Emission Computed Tomography Computed Tomography; Supranuclear Palsy, Progressive

2019
Neuronal oscillations of the pedunculopontine nucleus in progressive supranuclear palsy: Influence of levodopa and movement.
    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 2020, Volume: 131, Issue:2

    Topics: Aged; Antiparkinson Agents; Brain Waves; Female; Humans; Levodopa; Male; Movement; Pedunculopontine Tegmental Nucleus; Supranuclear Palsy, Progressive

2020
Involuntary Groaning Induced by Levodopa Therapy in a Patient With Progressive Supranuclear Palsy.
    JAMA neurology, 2020, 12-01, Volume: 77, Issue:12

    Topics: Aged, 80 and over; Dopamine Agents; Female; Humans; Levodopa; Supranuclear Palsy, Progressive

2020
Effectiveness of Levodopa in Patients with Multiple System Atrophy and Associated Clinicopathological Features.
    Internal medicine (Tokyo, Japan), 2021, Feb-01, Volume: 60, Issue:3

    Topics: Diagnosis, Differential; Humans; Levodopa; Magnetic Resonance Imaging; Multiple System Atrophy; Parkinson Disease; Putamen; Supranuclear Palsy, Progressive

2021
Is Levodopa Response a Valid Indicator of Parkinson's Disease?
    Movement disorders : official journal of the Movement Disorder Society, 2021, Volume: 36, Issue:4

    Topics: Humans; Levodopa; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Supranuclear Palsy, Progressive

2021
[Progressive supranuclear paralysis with levodopa-induced dyskinesia].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2021, Volume: 121, Issue:3

    Topics: Aged; Dyskinesias; Humans; Levodopa; Movement Disorders; Neurodegenerative Diseases; Supranuclear Palsy, Progressive

2021
Early suspicion of progressive supranuclear palsy using dopamine transporter imaging: an illustrative case presenting with levodopa-responsive parkinsonism.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2021, Volume: 42, Issue:8

    Topics: Dopamine Plasma Membrane Transport Proteins; Humans; Levodopa; Parkinson Disease; Parkinsonian Disorders; Supranuclear Palsy, Progressive

2021
Pain processing in atypical Parkinsonisms and Parkinson disease: A comparative neurophysiological study.
    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 2017, Volume: 128, Issue:10

    Topics: Aged; Female; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Pain; Pain Measurement; Parkinson Disease; Parkinsonian Disorders; Supranuclear Palsy, Progressive

2017
Corticobasal degeneration: key emerging issues.
    Journal of neurology, 2018, Volume: 265, Issue:2

    Topics: Aniline Compounds; Basal Ganglia; Carbolines; Cerebral Cortex; Dopamine Agents; History, 20th Century; Humans; Levodopa; Neurodegenerative Diseases; Positron-Emission Tomography; Supranuclear Palsy, Progressive; Thiazoles

2018
Evaluation of Retinal Changes in Progressive Supranuclear Palsy and Parkinson Disease.
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2018, Volume: 38, Issue:2

    Topics: Aged; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Nerve Fibers; Non-Randomized Controlled Trials as Topic; Optic Disk; Parkinson Disease; Prospective Studies; Retinal Diseases; Retinal Ganglion Cells; Supranuclear Palsy, Progressive; Tomography, Optical Coherence

2018
Levodopa-induced dystonia in a patient with possible progressive supranuclear palsy with progressive gait freezing.
    Journal of the neurological sciences, 2018, 05-15, Volume: 388

    Topics: Aged; Diagnosis, Differential; Dopamine Agents; Dystonia; Female; Gait Disorders, Neurologic; Humans; Levodopa; Supranuclear Palsy, Progressive

2018
[Dopaminergic drug-induced jaw-opening dystonia in a patient with progressive supranuclear palsy].
    Rinsho shinkeigaku = Clinical neurology, 2013, Volume: 53, Issue:4

    Topics: Aged; Dopamine Agents; Dystonia; Humans; Levodopa; Male; Mandibular Diseases; Supranuclear Palsy, Progressive

2013
The discriminating properties of an optoelectronic movement analysis method in patients with parkinsonism.
    Journal of motor behavior, 2013, Volume: 45, Issue:5

    Topics: Aged; Antiparkinson Agents; Diagnosis, Differential; Female; Humans; Levodopa; Linear Models; Logistic Models; Male; Middle Aged; Movement; Multiple System Atrophy; Parkinsonian Disorders; Posture; Reproducibility of Results; ROC Curve; Supranuclear Palsy, Progressive

2013
An 85-year old male with levodopa-responsive parkinsonism followed by dementia and supranuclear ophthalmoplegia caused by alzheimer-type pathology without Lewy bodies.
    Journal of Alzheimer's disease : JAD, 2014, Volume: 39, Issue:3

    Topics: Aged, 80 and over; Alzheimer Disease; Amphetamine; Dementia; Humans; Imaging, Three-Dimensional; Levodopa; Magnetic Resonance Imaging; Male; Parkinsonian Disorders; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon

2014
Responsiveness of dysphagia to acute L-Dopa challenge in progressive supranuclear palsy.
    Journal of neurology, 2014, Volume: 261, Issue:2

    Topics: Age of Onset; Aged; Deglutition; Deglutition Disorders; Dopamine Agents; Female; Humans; Levodopa; Male; Supranuclear Palsy, Progressive

2014
Progressive supra-nuclear palsy: frequency of cardinal extrapyramidal features at first presentation.
    Postgraduate medical journal, 2015, Volume: 91, Issue:1075

    Topics: Accidental Falls; Aged; Antiparkinson Agents; Diagnosis, Differential; Disease Progression; Early Diagnosis; Female; Humans; India; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Posture; Practice Guidelines as Topic; Prevalence; Supranuclear Palsy, Progressive

2015
Tremor in progressive supranuclear palsy.
    Parkinsonism & related disorders, 2016, Volume: 27

    Topics: Aged; Carbidopa; Dopamine Agents; Female; Humans; Levodopa; Male; Middle Aged; Retrospective Studies; Supranuclear Palsy, Progressive; Tremor

2016
Clinical features of dystonia in atypical parkinsonism.
    Arquivos de neuro-psiquiatria, 2008, Volume: 66, Issue:4

    Topics: Adult; Aged; Antiparkinson Agents; Cerebral Cortex; Dystonia; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Nerve Degeneration; Parkinsonian Disorders; Supranuclear Palsy, Progressive

2008
Parkinsonism, dysautonomia, REM behaviour disorder and visual hallucinations mimicking synucleinopathy in a patient with progressive supranuclear palsy.
    Journal of neurology, neurosurgery, and psychiatry, 2009, Volume: 80, Issue:5

    Topics: Antiparkinson Agents; Autonomic Nervous System Diseases; Brain; Fatal Outcome; Female; Hallucinations; Humans; Levodopa; Middle Aged; Parkinson Disease; REM Sleep Behavior Disorder; Supranuclear Palsy, Progressive; Synucleins; tau Proteins

2009
Progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) with fatal outcome, after the manifestation of an ampullary adenocarcinoma.
    Pancreas, 2010, Volume: 39, Issue:5

    Topics: Adenocarcinoma; Aged; Amantadine; Ampulla of Vater; Antiparkinson Agents; Common Bile Duct Neoplasms; Fatal Outcome; Female; Humans; Indoles; Levodopa; Supranuclear Palsy, Progressive

2010
Endoscopic characteristics and levodopa responsiveness of swallowing function in progressive supranuclear palsy.
    Movement disorders : official journal of the Movement Disorder Society, 2010, Jul-15, Volume: 25, Issue:9

    Topics: Aged; Antiparkinson Agents; Deglutition Disorders; Endoscopy; Female; Humans; Levodopa; Male; Middle Aged; Statistics as Topic; Statistics, Nonparametric; Supranuclear Palsy, Progressive

2010
Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease.
    Brain : a journal of neurology, 2012, Volume: 135, Issue:Pt 4

    Topics: Aged; Analysis of Variance; Biomechanical Phenomena; Case-Control Studies; Cognition; Disease Progression; Dopamine Agents; Female; Fingers; Handwriting; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Psychomotor Performance; Supranuclear Palsy, Progressive

2012
Electrophysiological features of lower motor neuron involvement in progressive supranuclear palsy.
    Journal of the neurological sciences, 2013, Jan-15, Volume: 324, Issue:1-2

    Topics: Action Potentials; Aged; Aging; Antiparkinson Agents; Electrodiagnosis; Electromyography; Female; Humans; Levodopa; Male; Middle Aged; Motor Neuron Disease; Motor Neurons; Muscle, Skeletal; Neural Conduction; Peripheral Nerves; Supranuclear Palsy, Progressive

2013
Levodopa-induced dyskinesia in an autopsy-proven case of progressive supranuclear palsy.
    Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:5

    Topics: Antiparkinson Agents; Brain; Culture Techniques; Dyskinesia, Drug-Induced; Fatal Outcome; Female; Humans; Levodopa; Middle Aged; Neurofibrillary Tangles; Supranuclear Palsy, Progressive

2002
Progressive supranuclear palsy diagnosis and confounding features: report on 16 autopsied cases.
    Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:6

    Topics: Aged; Aged, 80 and over; Brain; Diagnosis, Differential; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Neurologic Examination; Prognosis; Supranuclear Palsy, Progressive; Treatment Outcome

2002
Frequency of apraxia of eyelid opening in the general population and in patients with extrapyramidal disorders.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2002, Volume: 23 Suppl 2

    Topics: Adult; Age of Onset; Aged; Antiparkinson Agents; Apomorphine; Apraxias; Blepharospasm; Dystonia; Eyelids; Female; Humans; Italy; Levodopa; Male; Middle Aged; Parkinsonian Disorders; Supranuclear Palsy, Progressive

2002
Levodopa-induced oromandibular dystonia in progressive supranuclear palsy.
    Clinical neurology and neurosurgery, 2003, Volume: 105, Issue:2

    Topics: Aged; Antiparkinson Agents; Dystonia; Humans; Levodopa; Male; Mandible; Mouth; Supranuclear Palsy, Progressive

2003
Essential tremor course and disability: A clinicopathologic study of 20 cases.
    Neurology, 2004, Mar-23, Volume: 62, Issue:6

    Topics: Adrenergic beta-Antagonists; Age of Onset; Aged; Antiparkinson Agents; Disability Evaluation; Disease Progression; Essential Tremor; Female; Humans; Levodopa; Lewy Body Disease; Male; Propranolol; Saskatchewan; Supranuclear Palsy, Progressive

2004
[Cognitive deficits in progressive supranuclear palsy].
    Neurologia i neurochirurgia polska, 2003, Volume: 37 Suppl 5

    Topics: Aged; Antiparkinson Agents; Cognition Disorders; Female; Humans; Levodopa; Middle Aged; Neuropsychological Tests; Supranuclear Palsy, Progressive

2003
Measurements of transcallosally mediated cortical inhibition for differentiating parkinsonian syndromes.
    Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:5

    Topics: Aged; Antiparkinson Agents; Basal Ganglia Diseases; Corpus Callosum; Diagnosis, Differential; Electromyography; Humans; Levodopa; Magnetic Resonance Imaging; Magnetoencephalography; Middle Aged; Motor Cortex; Multiple System Atrophy; Muscle, Skeletal; Nerve Degeneration; Nerve Net; Neural Inhibition; Parkinsonian Disorders; Supranuclear Palsy, Progressive

2004
Kufor Rakeb disease: autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia.
    Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:10

    Topics: Adolescent; Adult; Age of Onset; Antiparkinson Agents; Child; Chromosomes, Human, Pair 1; Dementia; Female; Functional Laterality; Globus Pallidus; Humans; Levodopa; Magnetic Resonance Imaging; Male; Parkinsonian Disorders; Pedigree; Pyramidal Tracts; Severity of Illness Index; Supranuclear Palsy, Progressive

2005
Treatment of progressive supranuclear palsy and corticobasal degeneration.
    Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20 Suppl 12

    Topics: Amantadine; Cerebral Cortex; Cholinesterase Inhibitors; Corpus Striatum; Donepezil; Dopamine Agents; Dopamine Agonists; Dystonia; Globus Pallidus; Humans; Indans; Levodopa; Nerve Degeneration; Piperidines; Substantia Nigra; Supranuclear Palsy, Progressive

2005
Genetic analysis of SCA 2 and 3 repeat expansions in essential tremor and atypical Parkinsonism.
    Movement disorders : official journal of the Movement Disorder Society, 2007, Oct-15, Volume: 22, Issue:13

    Topics: Adult; Antiparkinson Agents; Ataxin-3; Ataxins; Cross-Sectional Studies; Diagnosis, Differential; DNA Mutational Analysis; Drug Resistance; Essential Tremor; Female; Genetic Testing; Genotype; Humans; Levodopa; Male; Middle Aged; Motor Skills Disorders; Multiple System Atrophy; Nerve Tissue Proteins; Neurologic Examination; Nuclear Proteins; Parkinsonian Disorders; Phenotype; Polymerase Chain Reaction; Repressor Proteins; Spinocerebellar Ataxias; Supranuclear Palsy, Progressive; Trinucleotide Repeat Expansion; Trinucleotide Repeats

2007
Subthalamic stimulation improves levodopa responsive symptoms in a case of progressive supranuclear palsy.
    Parkinsonism & related disorders, 2008, Volume: 14, Issue:4

    Topics: Deep Brain Stimulation; Dopamine Agents; Female; Humans; Levodopa; Longitudinal Studies; Magnetic Resonance Imaging; Middle Aged; Neuropsychological Tests; Retrospective Studies; Subthalamic Nucleus; Supranuclear Palsy, Progressive; Time Factors

2008
Excessive dopamine neuron loss in progressive supranuclear palsy.
    Movement disorders : official journal of the Movement Disorder Society, 2008, Mar-15, Volume: 23, Issue:4

    Topics: Aged; Disease Progression; Dopamine; Dopamine Agonists; Female; Humans; Levodopa; Male; Nerve Degeneration; Neurons; Substantia Nigra; Supranuclear Palsy, Progressive

2008
The auditory startle response in parkinsonism may reveal the extent but not type of pathology.
    Journal of neurology, 2008, Volume: 255, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Auditory Pathways; Blinking; Brain Stem; Dementia; Diagnosis, Differential; Facial Muscles; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Neck Muscles; Ocular Motility Disorders; Parkinsonian Disorders; Predictive Value of Tests; Reflex, Startle; Sensitivity and Specificity; Supranuclear Palsy, Progressive; Tauopathies

2008
Binswanger's disease presenting as levodopa-responsive parkinsonism: clinicopathologic study of three cases.
    Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:4

    Topics: Aged; Atrophy; Brain; Cerebral Arteries; Dementia, Multi-Infarct; Female; Humans; Intracranial Arteriosclerosis; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Supranuclear Palsy, Progressive

1995
[Gait disorders and repeated falls in Steele-Richardson-Olszewski syndrome].
    Tijdschrift voor gerontologie en geriatrie, 1995, Volume: 26, Issue:4

    Topics: Accidental Falls; Aged; Cognition Disorders; Female; Gait; Humans; Levodopa; Magnetic Resonance Spectroscopy; Movement Disorders; Neurotransmitter Agents; Posture; Saccades; Supranuclear Palsy, Progressive; Tomography, X-Ray Computed

1995
Levodopa-induced local cerebral blood flow changes in Parkinson's disease and related disorders.
    Journal of the neurological sciences, 1995, Volume: 128, Issue:2

    Topics: Adult; Aged; Carbidopa; Cerebrovascular Circulation; Drug Therapy, Combination; Female; Humans; Intracranial Arteriosclerosis; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Olivopontocerebellar Atrophies; Parkinson Disease; Parkinson Disease, Secondary; Supranuclear Palsy, Progressive; Tomography, X-Ray Computed; Treatment Outcome; Xenon

1995
[Parkinsonian features of Steele-Richardson-Olszewski syndrome].
    Revue neurologique, 1993, Volume: 149, Issue:1

    Topics: Aged; Atrophy; Brain Stem; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Supranuclear Palsy, Progressive; Tomography, X-Ray Computed

1993
Retrospective study of drug response in 87 patients with progressive supranuclear palsy.
    Clinical neuropharmacology, 1993, Volume: 16, Issue:4

    Topics: Amitriptyline; Carbidopa; Humans; Imipramine; Levodopa; Retrospective Studies; Supranuclear Palsy, Progressive

1993
Dopa-unresponsive pure akinesia or freezing. A condition within a wide spectrum of PSP?
    Advances in neurology, 1993, Volume: 60

    Topics: Benserazide; Carbidopa; Diagnosis, Differential; Drug Therapy, Combination; Humans; Levodopa; Motor Activity; Movement Disorders; Neurologic Examination; Ocular Motility Disorders; Parkinson Disease; Parkinson Disease, Secondary; Supranuclear Palsy, Progressive

1993
Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
    Journal of neurology, neurosurgery, and psychiatry, 1996, Volume: 60, Issue:6

    Topics: Aged; Antiparkinson Agents; Deglutition Disorders; Diagnosis, Differential; Diagnostic Errors; Diet Therapy; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Medical Records; Middle Aged; Parkinson Disease; Pneumonia, Aspiration; Supranuclear Palsy, Progressive; Survival Rate; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

1996
Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
    Brain : a journal of neurology, 1997, Volume: 120 ( Pt 1)

    Topics: Fixation, Ocular; Gait; Humans; Levodopa; Middle Aged; Movement Disorders; Parkinson Disease; Supranuclear Palsy, Progressive

1997
Nortriptyline for the treatment of depression in progressive supranuclear palsy.
    Journal of the American Geriatrics Society, 1997, Volume: 45, Issue:8

    Topics: Adrenergic Uptake Inhibitors; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depression; Dopamine Agents; Female; Fluoxetine; Humans; Levodopa; Nortriptyline; Remission Induction; Supranuclear Palsy, Progressive

1997
Analyzer workshop on the treatment of Parkinson's disease.
    European neurology, 1997, Volume: 38 Suppl 1

    Topics: Adult; Antiparkinson Agents; Bromocriptine; Cerebrovascular Disorders; Computer Simulation; Diagnosis, Differential; Forecasting; Humans; Levodopa; Middle Aged; Parkinson Disease; Supranuclear Palsy, Progressive; Tablets

1997
Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders.
    Movement disorders : official journal of the Movement Disorder Society, 1997, Volume: 12, Issue:6

    Topics: Aged; Antiparkinson Agents; Aspartic Acid; Atrophy; Cerebral Cortex; Choline; Corpus Striatum; Creatinine; Female; Globus Pallidus; Humans; Levodopa; Magnetic Resonance Spectroscopy; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Phosphocreatine; Protons; Putamen; Supranuclear Palsy, Progressive

1997
Computerized posturography analysis of progressive supranuclear palsy: a case-control comparison with Parkinson's disease and healthy controls.
    Archives of neurology, 2000, Volume: 57, Issue:10

    Topics: Aged; Antiparkinson Agents; Carbidopa; Case-Control Studies; Diagnosis, Computer-Assisted; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Parkinson Disease; Postural Balance; Posture; Severity of Illness Index; Supranuclear Palsy, Progressive

2000
A case of spontaneous arm levitation in progressive supranuclear palsy.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2000, Volume: 21, Issue:6

    Topics: Aged; Arm; Dopamine Agents; Dyskinesias; Humans; Levodopa; Male; Supranuclear Palsy, Progressive; Treatment Failure

2000
Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2001, Volume: 22, Issue:3

    Topics: Aged; Antiparkinson Agents; Disability Evaluation; Disease Progression; Female; Humans; Levodopa; Life Tables; Male; Middle Aged; Multiple System Atrophy; Supranuclear Palsy, Progressive

2001
[A case at Salpêtrière hospital November 1990. Parkinson syndrome with poor response to dopa therapy in a 64 year-old man].
    Revue neurologique, 1992, Volume: 148, Issue:8-9

    Topics: Atrophy; Corpus Striatum; Diagnosis, Differential; Drug Resistance; Humans; Levodopa; Male; Middle Aged; Olivopontocerebellar Atrophies; Parkinson Disease, Secondary; Substantia Nigra; Supranuclear Palsy, Progressive

1992
Local cerebral blood flow and its response to intravenous levodopa in progressive supranuclear palsy. Comparison with Parkinson's disease.
    Archives of neurology, 1992, Volume: 49, Issue:7

    Topics: Aged; Brain; Cerebrovascular Circulation; Female; Humans; Infusions, Intravenous; Levodopa; Male; Middle Aged; Parkinson Disease; Supranuclear Palsy, Progressive; Tomography, Emission-Computed

1992
[L-18F-dopa-PET in Parkinson-plus syndromes for the detection of a disordered presynaptic dopaminergic function].
    Nuklearmedizin. Nuclear medicine, 1992, Volume: 31, Issue:2

    Topics: Aged; Dopamine; Female; Fluorine Radioisotopes; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Shy-Drager Syndrome; Supranuclear Palsy, Progressive; Tomography, Emission-Computed

1992
Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.
    Annals of neurology, 1992, Volume: 31, Issue:2

    Topics: Adult; Aged; Caudate Nucleus; Corpus Striatum; Humans; Levodopa; Middle Aged; Nerve Degeneration; Parkinson Disease; Putamen; Raclopride; Receptors, Dopamine; Salicylamides; Substantia Nigra; Supranuclear Palsy, Progressive; Tomography, Emission-Computed

1992
The apomorphine test in parkinsonian syndromes.
    Journal of neurology, neurosurgery, and psychiatry, 1991, Volume: 54, Issue:10

    Topics: Aged; Apomorphine; Diagnosis, Differential; Female; Humans; Levodopa; Lewy Bodies; Male; Middle Aged; Muscular Atrophy; Neurologic Examination; Olivopontocerebellar Atrophies; Parkinson Disease; Parkinson Disease, Secondary; Prognosis; Supranuclear Palsy, Progressive

1991
Autonomic involvement in extrapyramidal and cerebellar disorders.
    Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 1991, Volume: 1, Issue:2

    Topics: Adult; Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Cerebellar Diseases; Cognition Disorders; Female; Heart Rate; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Reflex; Shy-Drager Syndrome; Supranuclear Palsy, Progressive; Valsalva Maneuver

1991
[3H]MK-801 binding to NMDA glutamatergic receptors in Parkinson's disease and progressive supranuclear palsy.
    Brain research, 1991, Nov-22, Volume: 565, Issue:1

    Topics: Aged; Brain; Dizocilpine Maleate; Humans; Kinetics; Levodopa; Organ Specificity; Parkinson Disease; Receptors, N-Methyl-D-Aspartate; Reference Values; Supranuclear Palsy, Progressive

1991
[Progressive supranuclear palsy: clinical report on 7 cases and review of literature].
    Journal of the Formosan Medical Association = Taiwan yi zhi, 1990, Volume: 89, Issue:7

    Topics: Aged; Electronystagmography; Female; Humans; Levodopa; Male; Middle Aged; Supranuclear Palsy, Progressive; Theta Rhythm; Tomography, X-Ray Computed

1990
Excessive yawning and progressive supranuclear palsy.
    The International journal of neuroscience, 1987, Volume: 34, Issue:1-2

    Topics: Aged; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Middle Aged; Supranuclear Palsy, Progressive; Yawning

1987
[An autopsy case of progressive supranuclear palsy showing "pure akinesia without rigidity and tremor and with no effect by L-dopa therapy (Imai)"].
    No to shinkei = Brain and nerve, 1987, Volume: 39, Issue:2

    Topics: Aged; Brain; Bulbar Palsy, Progressive; Diagnosis, Differential; Female; Humans; Levodopa; Limbic System; Ophthalmoplegia; Parkinson Disease; Supranuclear Palsy, Progressive

1987